Anifrolumab-containing medicinal products
Titre original de l'avis
Czechia – Immunosuppressive agents – Léčivé přípravky s obsahem anifrolumabu
Score d'opportunité
Pourquoi ce score ?
Opportunité
55 / 100
Complexité
67 / 100
Facteurs de risque
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- Fakultní nemocnice Hradec Králové
- Pays
- République tchèque
- CPV
- 33652300 - Immunosuppressive agents
- Date limite
- Nov 10, 2026
- Valeur estimée
- CZK 9.1M (approx. EUR 372k)
Aperçu
Moderate opportunityFaits clés
- CZK 9.1M estimated value
- Supplies contract
- 1 lot
- Duration 4 YEAR
- Ongoing supply of medicinal products containing anifrolumab.
- Deliveries are to be made according to the contracting authority's current needs.
Afficher le résumé complet
Open procedure for four years of ongoing supplies of medicinal products containing anifrolumab, classified as immunosuppressive agents. The estimated value is CZK 9,064,670 and performance is in Czechia. Electronic submission is required and the stated language is Czech. Procurement documents are referenced but no extracted document text was provided, so key commercial, technical, eligibility, and submission details remain unverified.
Risques
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- The procedure is an open procedure.
Administrative
- Electronic submission is required.
- The stated language is Czech.
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Acheteur
Localisation
Hradec Králové - Nový Hradec Králové, CZE
Site web
Profil acheteur
Identifiant
00179906
Activité
Health
Lots (1)
LOT-0001
Anifrolumab-containing medicinal products
The lot covers ongoing deliveries of medicinal products containing anifrolumab according to the contracting authority's current needs over a four-year period. Lot-specific quantities, product specifications, delivery arrangements, and value are not provided in the structured data.
EUR 372k
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
nejnižší celková nabídková cena v Kč bez DPH/4 roky.
Afficher les données TED originales
Titre original du lot
Léčivé přípravky s obsahem anifrolumabu
Description TED originale
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem anifrolumabu po dobu 4 let dle aktuálních potřeb zadavatele.
Détails de la procédure
- Date de publication
- 11 Oct 2026
- Langues
- Czech
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 700339-2026
Documents (1)
Score d'opportunité
Pourquoi ce score ?
Opportunité
55 / 100
Complexité
67 / 100
Facteurs de risque
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications